Novel genetic variants in HDAC2 and PPARGC1A of the CREB‐binding protein pathway predict survival of non‐small‐cell lung cancer-Reference-Cited by-同舟云学术

Novel genetic variants in HDAC2 and PPARGC1A of the CREB‐binding protein pathway predict survival of non‐small‐cell lung cancer

Published:2019-11-12 Issue:1 Volume:59 Page:104-115
ISSN:0899-1987
Container-title:Molecular Carcinogenesis
language:en
Short-container-title:Mol Carcinog

Author:

Tang Dongfang¹²³,Zhao Yu Chen²³,Qian Danwen²³,Liu Hongliang²³,Luo Sheng⁴,Patz Edward F.²⁵,Moorman Patricia G.²⁶,Su Li⁷,Shen Sipeng⁷^ORCID,Christiani David C.⁷⁸,Glass Carolyn⁷⁹,Gao Wen¹,Wei Qingyi²³¹⁰^ORCID

Affiliation:

1. Department of Thoracic Surgery, Shanghai Key Laboratory of Clinical Geriatric Medicine Huadong Hospital Affiliated to Fudan University Shanghai China

2. Duke Cancer Institute Duke University Medical Center Durham North Carolina

3. Department of Population Health Sciences Duke University School of Medicine Durham North Carolina

4. Department of Biostatistics and Bioinformatics Duke University School of Medicine Durham North Carolina

5. Department of Radiology and Department of Pharmacology and Cancer Biology Duke University Medical Center Durham North Carolina

6. Department of Community and Family Medicine Duke University Medical Center North Carolina

7. Department of Environmental Health and Department of Epidemiology Harvard School of Public Health Boston Massachusetts

8. Department of Medicine Massachusetts General Hospital Boston Massachusetts

9. Department of Pathology Duke University School of Medicine Durham North Carolina

10. Department of Medicine Duke University School of Medicine Durham North Carolina

Funder

National Institutes of Health

Fudan University

V Foundation for Cancer Research

Publisher

Wiley

Subject

Cancer Research,Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mc.23132

Reference56 articles.

1. Potential Molecular Targets in the Treatment of Lung Cancer Using siRNA Technology

2. Histologic Lung Cancer Incidence Rates and Trends Vary by Race/Ethnicity and Residential County

3. Second-Line Treatment of Non-Small Cell Lung Cancer: New Developments for Tumours Not Harbouring Targetable Oncogenic Driver Mutations

4. Genetic variants and risk of lung cancer in never smokers: a genome-wide association study

5. Single Nucleotide Polymorphisms (SNPs) in Non-Small Cell Lung Cancer (NSCLC) Patients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. METTL3-mediated m6A modification enhances ZDHHC16 expression in nonsmall- cell lung cancer patients, attenuating ferroptosis by suppressing CREB ubiquitination;Cellular and Molecular Biology;2024-02-29

2. The HDAC2–MTA3 interaction induces nonsmall cell lung cancer cell migration and invasion by targeting c‐Myc and cyclin D1;Molecular Carcinogenesis;2023-07-04

3. Genetic Variants in Histone Modification Regions Predict Clinical Outcomes of Pemetrexed Chemotherapy in Lung Adenocarcinoma;Oncology;2022-10-18

4. Histone acetylation modification regulator-mediated tumor microenvironment infiltration characteristics and prognostic model of lung adenocarcinoma patients;Journal of Thoracic Disease;2022-10

5. Potentially functional variants of MAP3K14 in the NF-κB signaling pathway genes predict survival of HBV-related hepatocellular carcinoma patients;Frontiers in Oncology;2022-09-02